277 related articles for article (PubMed ID: 21981027)
1. Effect of early EBV and/or CMV viremia on graft function and acute cellular rejection in pediatric liver transplantation.
Indolfi G; Heaton N; Smith M; Mieli-Vergani G; Zuckerman M
Clin Transplant; 2012; 26(1):E55-61. PubMed ID: 21981027
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous monitoring by real-time polymerase chain reaction of epstein-barr virus, human cytomegalovirus, and human herpesvirus-6 in juvenile and adult liver transplant recipients.
Ono Y; Ito Y; Kaneko K; Shibata-Watanabe Y; Tainaka T; Sumida W; Nakamura T; Kamei H; Kiuchi T; Ando H; Kimura H
Transplant Proc; 2008 Dec; 40(10):3578-82. PubMed ID: 19100443
[TBL] [Abstract][Full Text] [Related]
3. OKT3 and ganciclovir treatments are possibly related to the presence of Epstein-Barr virus in serum after liver transplantation.
Barkholt L; Linde A; Falk KI
Transpl Int; 2005 Jul; 18(7):835-43. PubMed ID: 15948864
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus and Epstein-Barr virus infections among pediatric kidney transplant recipients at a center using universal Valganciclovir Prophylaxis.
Paulsen G; Cumagun P; Mixon E; Fowler K; Feig D; Shimamura M
Pediatr Transplant; 2019 May; 23(3):e13382. PubMed ID: 30786115
[TBL] [Abstract][Full Text] [Related]
5. Risk factors and clinical outcomes of pediatric liver transplant recipients with post-transplant lymphoproliferative disease in a multi-ethnic Asian cohort.
Huang JG; Tan MYQ; Quak SH; Aw MM
Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29071779
[TBL] [Abstract][Full Text] [Related]
6. Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies.
Xuan L; Huang F; Fan Z; Zhou H; Zhang X; Yu G; Zhang Y; Liu C; Sun J; Liu Q
J Hematol Oncol; 2012 Aug; 5():46. PubMed ID: 22856463
[TBL] [Abstract][Full Text] [Related]
7. High intrahepatic HHV-6 virus loads but neither CMV nor EBV are associated with decreased graft survival after diagnosis of graft hepatitis.
Pischke S; Gösling J; Engelmann I; Schlue J; Wölk B; Jäckel E; Meyer-Heithuis C; Lehmann U; Strassburg CP; Barg-Hock H; Becker T; Manns MP; Schulz T; Wedemeyer H; Heim A
J Hepatol; 2012 May; 56(5):1063-1069. PubMed ID: 22245897
[TBL] [Abstract][Full Text] [Related]
8. Risk Factors for and the Clinical Impact of Cytomegalovirus and Epstein-Barr Virus Infections in Pediatric Recipients of TCR-α/β- and CD19-Depleted Grafts.
Laberko A; Bogoyavlenskaya A; Shelikhova L; Shekhovtsova Z; Balashov D; Voronin K; Kurnikova E; Boyakova E; Raykina E; Brilliantova V; Pirumova V; Novichkova G; Maschan A; Maschan M
Biol Blood Marrow Transplant; 2017 Mar; 23(3):483-490. PubMed ID: 28039080
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of pretransplant EBV and CMV serostatus in relation to posttransplant non-Hodgkin lymphoma.
Opelz G; Daniel V; Naujokat C; Döhler B
Transplantation; 2009 Oct; 88(8):962-7. PubMed ID: 19855238
[TBL] [Abstract][Full Text] [Related]
10. EBV, CMV, and BK viral infections in pediatric kidney transplantation: Frequency, risk factors, treatment, and outcomes.
Levi S; Davidovits M; Alfandari H; Dagan A; Borovitz Y; Bilavsky E; Landau D; Haskin O
Pediatr Transplant; 2022 May; 26(3):e14199. PubMed ID: 34817112
[TBL] [Abstract][Full Text] [Related]
11. Relationship Among Viremia/Viral Infection, Alloimmunity, and Nutritional Parameters in the First Year After Pediatric Kidney Transplantation.
Ettenger R; Chin H; Kesler K; Bridges N; Grimm P; Reed EF; Sarwal M; Sibley R; Tsai E; Warshaw B; Kirk AD
Am J Transplant; 2017 Jun; 17(6):1549-1562. PubMed ID: 27989013
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr viremia levels after pediatric liver transplantation as measured by real-time polymerase chain reaction.
Kullberg-Lindh C; Ascher H; Saalman R; Olausson M; Lindh M
Pediatr Transplant; 2006 Feb; 10(1):83-9. PubMed ID: 16499593
[TBL] [Abstract][Full Text] [Related]
13. Co-Reactivation of Cytomegalovirus and Epstein-Barr Virus Was Associated With Poor Prognosis After Allogeneic Stem Cell Transplantation.
Zhou JR; Shi DY; Wei R; Wang Y; Yan CH; Zhang XH; Xu LP; Liu KY; Huang XJ; Sun YQ
Front Immunol; 2020; 11():620891. PubMed ID: 33664733
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of valganciclovir for prevention of infections with cytomegalovirus and Epstein-Barr virus after kidney transplant in children.
Cameron BM; Kennedy SE; Rawlinson WD; Mackie FE
Pediatr Transplant; 2017 Feb; 21(1):. PubMed ID: 27704725
[TBL] [Abstract][Full Text] [Related]
15. No effect of treatment with intravenous ganciclovir on Epstein-Barr virus viremia demonstrated after pediatric liver transplantation.
Østensen AB; Sanengen T; Holter E; Line PD; Almaas R
Pediatr Transplant; 2017 Sep; 21(6):. PubMed ID: 28653462
[TBL] [Abstract][Full Text] [Related]
16. Comparison of serum and whole blood levels of cytomegalovirus and Epstein-Barr virus DNA.
Kullberg-Lindh C; Olofsson S; Brune M; Lindh M
Transpl Infect Dis; 2008 Oct; 10(5):308-15. PubMed ID: 18466193
[TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus infection: its incidence and management in cytomegalovirus-seropositive living related liver transplant recipients: a single-center experience.
Wadhawan M; Gupta S; Goyal N; Vasudevan KR; Makki K; Dawar R; Sardana R; Lal N; Kumar A
Liver Transpl; 2012 Dec; 18(12):1448-55. PubMed ID: 22903934
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous quantification of Epstein-Barr virus, cytomegalovirus, and human herpesvirus 6 DNA in samples from transplant recipients by multiplex real-time PCR assay.
Wada K; Kubota N; Ito Y; Yagasaki H; Kato K; Yoshikawa T; Ono Y; Ando H; Fujimoto Y; Kiuchi T; Kojima S; Nishiyama Y; Kimura H
J Clin Microbiol; 2007 May; 45(5):1426-32. PubMed ID: 17376882
[TBL] [Abstract][Full Text] [Related]
19. Subclinical cytomegalovirus and Epstein-Barr virus viremia are associated with adverse outcomes in pediatric renal transplantation.
Li L; Chaudhuri A; Weintraub LA; Hsieh F; Shah S; Alexander S; Salvatierra O; Sarwal MM
Pediatr Transplant; 2007 Mar; 11(2):187-95. PubMed ID: 17300499
[TBL] [Abstract][Full Text] [Related]
20. Response of elevated Epstein-Barr virus DNA levels to therapeutic changes in pediatric liver transplant patients: 56-month follow up and outcome.
Holmes RD; Orban-Eller K; Karrer FR; Rowe DT; Narkewicz MR; Sokol RJ
Transplantation; 2002 Aug; 74(3):367-72. PubMed ID: 12177616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]